| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/17/2005 | US20050058647 Newly identified polypeptide and polynucleotides for diagnosis of new compounds |
| 03/17/2005 | US20050058633 Stem cells that transform to beating cardiomyocytes |
| 03/17/2005 | US20050058627 TTK in diagnosis and as a therapeutic target in cancer |
| 03/17/2005 | US20050058626 Vaccine against pathogens |
| 03/17/2005 | US20050058604 Phthalamide-lanthanide complexes for use as luminescent markers |
| 03/17/2005 | US20050057749 Novel optical architectures for microvolume laser-scanning cytometers |
| 03/17/2005 | US20050056552 Increasing bias for oxygen production in an electrode system |
| 03/17/2005 | US20050056551 Using oxidase; generating hydrogen peroxide; reduction of hydrogen peroxxide using horseradish peroxidase |
| 03/17/2005 | DE10340395A1 In vitro detection of systemic inflammatory response syndrome and related conditions, for e.g. monitoring progression, comprises detecting abnormal expression of disease-related genes |
| 03/17/2005 | DE10104937B4 Fluoreszenzpolarisation 2 Fluorescence polarization 2 |
| 03/17/2005 | CA2540378A1 Method for the detection of cytosine methylations in dna with the aid of scorpion primers |
| 03/17/2005 | CA2538270A1 Primers for use in detecting beta-lactamases |
| 03/17/2005 | CA2538189A1 Novel markers for alternatively activated macrophages |
| 03/17/2005 | CA2538012A1 Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof |
| 03/17/2005 | CA2537955A1 Diagnostic marker for ovarian cancer |
| 03/17/2005 | CA2537798A1 Cytidine deaminase activators, deoxycytidine deaminase activators, vif antagonists, and methods of screening for molecules thereof |
| 03/17/2005 | CA2537768A1 Genetic analysis for stratification of breast cancer risk |
| 03/17/2005 | CA2537765A1 Methods and compositions for the prevention and treatment of genitourinary disorders, including pre-term labor and leiomyomas |
| 03/17/2005 | CA2537254A1 Methods for identifying, diagnosing, and predicting survival of lymphomas |
| 03/17/2005 | CA2536793A1 Novel ubp8rp polypeptides and their use in the treatment of psoriasis |
| 03/17/2005 | CA2536782A1 Recombinant production of antimicrobial agents |
| 03/17/2005 | CA2536650A1 Transformed plants with improved growth characteristics due to increased expression of b-type cdk and methods for making same |
| 03/17/2005 | CA2535770A1 Method for detecting cancer cells and monitoring cancer therapy |
| 03/17/2005 | CA2535734A1 Composition for the prevention/treatment of hbv infections and hbv-mediated diseases |
| 03/17/2005 | CA2532211A1 Water-soluble tetrazolium compounds |
| 03/17/2005 | CA2531087A1 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 03/17/2005 | CA2526398A1 Human monoclonal antibodies against bacillus anthracis protective antigen |
| 03/17/2005 | CA2525972A1 Methods for identifying inhibitors |
| 03/17/2005 | CA2517264A1 Ebola peptides and immunogenic compositions containing same |
| 03/16/2005 | EP1515144A1 Method of assay with sulfonic acid compound and nitro compound |
| 03/16/2005 | EP1515143A1 Method of assay by oxidation-reduction reaction with formazan |
| 03/16/2005 | EP1514946A1 Method of detecting gene polymorphism |
| 03/16/2005 | EP1514944A1 High-throughput-Assay with high sensitivity for measuring of the activity of beta-adrenergic receptor kinase and for determining the impact of test substances on such activity |
| 03/16/2005 | EP1514942A1 Method of searching substane having antidiabetic activity |
| 03/16/2005 | EP1514941A2 Paraquat resistance gene and a vascular tissue- and trichome-specific promotor |
| 03/16/2005 | EP1514937A1 Production of vaccines |
| 03/16/2005 | EP1514936A2 A novel method to isolate mutants and to clone the complementing gene |
| 03/16/2005 | EP1514932A2 Glucagon receptors |
| 03/16/2005 | EP1514931A1 Immunosuppressant target proteins |
| 03/16/2005 | EP1514926A1 Inflammatory skin disease-related slurp-2 gene and utilization thereof |
| 03/16/2005 | EP1514925A1 Method of screening compound affecting amyloid beta production |
| 03/16/2005 | EP1514920A1 Methods and device for adhesive control of internal cell organisation |
| 03/16/2005 | EP1514876A2 Antibody against prostate stem cell antigen (PSCA) |
| 03/16/2005 | EP1514213A2 Computer systems and methods for subdividing a complex disease into component diseases |
| 03/16/2005 | EP1514119A2 DIAGNOSTIC POLYMORPHISM OF 11s-HYDROXYSTEROID DEHYDROGENASE USEFUL FOR IDENTIFYING RISK OF DEVELOPING ALZHEIMER S DISEA SE |
| 03/16/2005 | EP1514116A1 Oxaliplatin anti-resistance agent |
| 03/16/2005 | EP1514115A2 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof |
| 03/16/2005 | EP1514107A2 Methods for quantitative proteome analysis of glycoproteins |
| 03/16/2005 | EP1514105A2 Methods of modulating tubulin deacetylase activity |
| 03/16/2005 | EP1514104A1 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species |
| 03/16/2005 | EP1514079A1 Biosensor having electrode for determining the rate of flow of a fluid |
| 03/16/2005 | EP1513959A2 Antiviral inhibitions of capsid proteins |
| 03/16/2005 | EP1513958A1 Compositions and methods for detecting hepatitis b virus |
| 03/16/2005 | EP1513957A2 Nucleic acid sequencing by signal stretching and data integration |
| 03/16/2005 | EP1513956A2 Assay to detect replication competent viruses |
| 03/16/2005 | EP1513955A2 Diagnostic and therapeutic use of cyp11a1 for neurodegenerative diseases |
| 03/16/2005 | EP1513954A2 Device and method of use for detection and characterization of pathogens and biological materials |
| 03/16/2005 | EP1513953A1 Method for high-throughput integrated chemical and biochemical reactions |
| 03/16/2005 | EP1513952A2 Composition and methods for obtaining nucleic acids from sputum |
| 03/16/2005 | EP1513950A1 Application of cantilevers in nucleic acid sequencing |
| 03/16/2005 | EP1513949A1 Improved dna amplification apparatus and method |
| 03/16/2005 | EP1513948A1 Integrated micro array system and methods therefor |
| 03/16/2005 | EP1513947A2 Method for designing pdk1 modulators |
| 03/16/2005 | EP1513946A1 POLYPEPTIDES HAVING a- H-a-AMINO ACID AMIDE RACEMASE ACTIVITY AND NUCLEIC ACIDS ENCODING THE SAME |
| 03/16/2005 | EP1513944A2 Improvements for combinatorial oligonucleotide pcr |
| 03/16/2005 | EP1513937A2 A method for the stimultaneaous production of multiple proteins; vectors and cells for use therein |
| 03/16/2005 | EP1513932A1 Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment |
| 03/16/2005 | EP1513877A1 Marker for stem cells and its use |
| 03/16/2005 | EP1513876A2 Human 5-ht7 receptor promoter sequence |
| 03/16/2005 | EP1513870A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same |
| 03/16/2005 | EP1513869A2 Polynucleotides for the detection and quantification of hepatitis b virus nucleic acids |
| 03/16/2005 | EP1513864A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/16/2005 | EP1513860A2 P450 enzymes, nucleic acids encoding them and methods of making and using them |
| 03/16/2005 | EP1513859A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 03/16/2005 | EP1513553A1 Methods and materials for treating inflammatory conditions |
| 03/16/2005 | EP1438586A4 Fret protease assays for clostridial toxins |
| 03/16/2005 | EP1282688B1 Ammonia-oxidizing bacteria |
| 03/16/2005 | EP1268784B1 Genes involved in intestinal inflammatory diseases and use thereof |
| 03/16/2005 | EP1266037A4 High throughput screening by measurement of intracellular calcium levels |
| 03/16/2005 | EP1242626A4 Detection of nucleic acids |
| 03/16/2005 | EP1203091B1 Chemiluminescent substrates of hydrolytic enzymes such as phosphatases |
| 03/16/2005 | EP1181392A4 Detection of chromosome copy number changes to distinguish melanocytic nevi from malignant melanoma |
| 03/16/2005 | EP1147218B1 Selection procedure using prodrug/enzyme system |
| 03/16/2005 | EP1027456B1 Expression profiles in adult and fetal organs |
| 03/16/2005 | EP0994962A4 An indexed library of cells containing genomic modifications and methods of making and utilizing the same |
| 03/16/2005 | EP0716604B1 Thiol-derivatized nucleosides and oligonucleosides |
| 03/16/2005 | CN1596369A Base sequence detecting device and base sequence automatic analyzer |
| 03/16/2005 | CN1596314A Method of determining a chemotherapeutic regimen based on ercc1 and ts expression |
| 03/16/2005 | CN1596306A Methods of screening for introduction of DNA into a target cell |
| 03/16/2005 | CN1596301A Gamma-glutamylcystein-producing yeast and method of screening the same |
| 03/16/2005 | CN1596269A A novel G protein-coupled receptor, gave 10 |
| 03/16/2005 | CN1596265A Analysis of circulating tumor cells, fragments, and debris |
| 03/16/2005 | CN1596264A Differentially expressed genes associated with obesity and type 2 diabetes |
| 03/16/2005 | CN1595162A Use of protein biological chips in detecting biological marks in blood of SARS patients |
| 03/16/2005 | CN1595154A Refined citric acid quantitative determination reagent |
| 03/16/2005 | CN1595153A Refined fructose enzyme method quantitative determination reagent |
| 03/16/2005 | CN1595097A Process for preparing tissue chips and apparatus thereof |
| 03/16/2005 | CN1594595A Preparation method for chicken skeletal muscle expression sequence label gene chip |
| 03/16/2005 | CN1594594A Silver dyeing method |
| 03/16/2005 | CN1594593A Process for screening anti hepatitis C virus drug |